Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanny Chalmin

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Molecular Nutrition & Food Research|April 20, 2020
Red Wine Extract Disrupts Th17 Lymphocyte Differentiation in a Colorectal Cancer ContextPauline Chalons, Flavie Courtaut, Emeric Limagne, et al.
Plos One|June 14, 2013
Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cellsHélène Bugaut, Mélanie Bruchard, Hélène Berger, et al.
The Journal of Clinical Investigation|October 3, 2008
CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancerStephan Roux, Lionel Apetoh, Fanny Chalmin, et al.
Journal for Immunotherapy of Cancer|May 10, 2020
Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in miceThomas Pilot, Aurélie Fratti, Chloé Thinselin, et al.
Nature Communications|December 14, 2017
IRF8-dependent molecular complexes control the Th9 transcriptional programEtienne Humblin, Marion Thibaudin, Fanny Chalmin, et al.
Nature Immunology|June 30, 2014
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cellsFrédérique Végran, Hélène Berger, Romain Boidot, et al.
Nature Medicine|December 4, 2012
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growthMélanie Bruchard, Grégoire Mignot, Valentin Derangère, et al.
Nature Immunology|February 1, 2022
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responsesMélanie Bruchard, Mannon Geindreau, Anaïs Perrichet, et al.
Oncoimmunology|June 7, 2018
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancerMagalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange, et al.
Cellular & Molecular Immunology|April 8, 2025
The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into TregsThéo Accogli, Christophe Hibos, Lylou Milian, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Molecular Nutrition & Food Research|April 20, 2020
Red Wine Extract Disrupts Th17 Lymphocyte Differentiation in a Colorectal Cancer ContextPauline Chalons, Flavie Courtaut, Emeric Limagne, et al.
Plos One|June 14, 2013
Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cellsHélène Bugaut, Mélanie Bruchard, Hélène Berger, et al.
The Journal of Clinical Investigation|October 3, 2008
CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancerStephan Roux, Lionel Apetoh, Fanny Chalmin, et al.
Journal for Immunotherapy of Cancer|May 10, 2020
Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in miceThomas Pilot, Aurélie Fratti, Chloé Thinselin, et al.
Nature Communications|December 14, 2017
IRF8-dependent molecular complexes control the Th9 transcriptional programEtienne Humblin, Marion Thibaudin, Fanny Chalmin, et al.
Nature Immunology|June 30, 2014
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cellsFrédérique Végran, Hélène Berger, Romain Boidot, et al.
Nature Medicine|December 4, 2012
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growthMélanie Bruchard, Grégoire Mignot, Valentin Derangère, et al.
Nature Immunology|February 1, 2022
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responsesMélanie Bruchard, Mannon Geindreau, Anaïs Perrichet, et al.
Oncoimmunology|June 7, 2018
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancerMagalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange, et al.
Cellular & Molecular Immunology|April 8, 2025
The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into TregsThéo Accogli, Christophe Hibos, Lylou Milian, et al.
Pageof 3